Čeština 
Slovenčina 
Română 
Deutsch DERIDUST
Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH)
QUALITATIVE AND QUANTITATIVE COMPOSITION
- Each capsule contains 0.5 mg dutasteride.
Excipient with known effect: Each capsule contains lecithin (which may contain soybean oil) (E322)
THERAPEUTICAL INDICATIONS
Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH).
Reduce the risk of acute urinary retention (URA) and the need for surgery in patients with moderate to severe symptoms of BPH.
PRESCRIPTION AND WITHDRAWAL
The medicine is issued on prescription and is reimbursed within the Health Insurance System.
